Jump to content

User:Madhero88/Papers

This user has rollback rights on the English Wikipedia.
From Wikipedia, the free encyclopedia
File:Vista-package wordprocessing.png

http://diberri.dyndns.org/cgi-bin/templatefiller/?type=&id= Generator

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

Hypertension

[edit]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

[39]

[40]

[41]

[42]

[43]

[44]

[45]

[46]





















Papers

[edit]
  1. ^Kenefick RW, Hazzard MP, Mahood NV, Castellani JW (2004). "Thirst sensations and AVP responses at rest and during exercise-cold exposure".Med Sci Sports Exerc.36(9): 1528–34.PMID15354034.{{cite journal}}:Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  2. ^Falk B (1998). "Effects of thermal stress during rest and exercise in the paediatric population".Sports Med.25(4): 221–40.PMID9587181.{{cite journal}}:Unknown parameter|month=ignored (help)
  3. ^Sawka MN (1992). "Physiological consequences of hypohydration: exercise performance and thermoregulation".Med Sci Sports Exerc.24(6): 657–70.PMID1602938.{{cite journal}}:Unknown parameter|month=ignored (help)
  4. ^Ragonesi AJ, Antick JR (2008). "Physiological responses to violence reported in the news".Percept Mot Skills.107(2): 383–95.PMID19093600.{{cite journal}}:Unknown parameter|month=ignored (help)
  5. ^Wallien MS, van Goozen SH, Cohen-Kettenis PT (2007). "Physiological correlates of anxiety in children with gender identity disorder".Eur Child Adolesc Psychiatry.16(5): 309–15.doi:10.1007/s00787-007-0602-7.PMID17401613.{{cite journal}}:Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^Farooqi IS, O'Rahilly S (2009)."Leptin: a pivotal regulator of human energy homeostasis".Am. J. Clin. Nutr.89(3): 980S–984S.doi:10.3945/ajcn.2008.26788C.PMID19211814.{{cite journal}}:Unknown parameter|month=ignored (help)
  7. ^Basdevant A, Ciangura C (2007). "[Leptin: from gene to energy balance]".Bull. Acad. Natl. Med.(in French).191(4–5): 887–94, discussion 894–5.PMID18225443.
  8. ^Enriori PJ, Evans AE, Sinnayah P, Cowley MA (2006)."Leptin resistance and obesity".Obesity (Silver Spring).14 Suppl 5: 254S–258S.doi:10.1038/oby.2006.319.PMID17021377.{{cite journal}}:Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  9. ^Jang EH, Moon JS, Ko JH; et al. (2008). "Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase".Int J Obes (Lond).32(7): 1161–70.doi:10.1038/ijo.2008.60.PMID18414417.{{cite journal}}:Explicit use of et al. in:|author=(help);Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  10. ^Codner E (2008). "Estrogen and type 1 diabetes mellitus".Pediatr Endocrinol Rev.6(2): 228–34.PMID19202509.{{cite journal}}:Unknown parameter|month=ignored (help)
  11. ^Jacobson-Dickman E, Lee MM (2009). "The influence of endocrine disruptors on pubertal timing".Curr Opin Endocrinol Diabetes Obes.16(1): 25–30.PMID19115521.{{cite journal}}:Unknown parameter|month=ignored (help)
  12. ^Loomba-Albrecht LA, Styne DM (2009). "Effect of puberty on body composition".Curr Opin Endocrinol Diabetes Obes.16(1): 10–5.PMID19115520.{{cite journal}}:Unknown parameter|month=ignored (help)
  13. ^DiVall SA, Radovick S (2009). "Endocrinology of female puberty".Curr Opin Endocrinol Diabetes Obes.16(1): 1–4.PMID19115519.{{cite journal}}:Unknown parameter|month=ignored (help)
  14. ^Lewis K, Lee PA (2009)."Endocrinology of male puberty".Curr Opin Endocrinol Diabetes Obes.16(1): 5–9.doi:10.1097/MED.0b013e32832029be.PMID19104233.{{cite journal}}:Unknown parameter|month=ignored (help)
  15. ^Wilson LA, Wayman CP, Jackson VM (2009)."Neuropeptide Modulation of a Lumbar Spinal Reflex: Potential Implications for Female Sexual Function".J Sex Med.doi:10.1111/j.1743-6109.2008.01150.x.PMID19170864.{{cite journal}}:Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  16. ^Vignozzi L, Filippi S, Morelli A; et al. (2008). "Regulation of epididymal contractility during semen emission, the first part of the ejaculatory process: a role for estrogen".J Sex Med.5(9): 2010–6, quiz 2017.doi:10.1111/j.1743-6109.2008.00914.x.PMID18783525.{{cite journal}}:Explicit use of et al. in:|author=(help);Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  17. ^Burri A, Heinrichs M, Schedlowski M, Kruger TH (2008)."The acute effects of intranasal oxytocin administration on endocrine and sexual function in males".Psychoneuroendocrinology.33(5): 591–600.doi:10.1016/j.psyneuen.2008.01.014.PMID18375074.{{cite journal}}:Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
  18. ^Kazakova SB, Sapronov NS (2008). "[Comparative analysis of the effects of estrogens and tamoxifen on the brain higher functions]".Eksp Klin Farmakol(in Russian).71(6): 49–53.PMID19140518.
  19. ^Hammock EA, Young LJ (2006)."Oxytocin, vasopressin and pair bonding: implications for autism".Philos. Trans. R. Soc. Lond., B, Biol. Sci.361(1476): 2187–98.doi:10.1098/rstb.2006.1939.PMC1764849.PMID17118932.{{cite journal}}:Unknown parameter|month=ignored (help)
  20. ^Insel TR, Winslow JT, Wang Z, Young LJ (1998). "Oxytocin, vasopressin, and the neuroendocrine basis of pair bond formation".Adv. Exp. Med. Biol.449:215–24.PMID10026808.{{cite journal}}:CS1 maint: multiple names: authors list (link)
  21. ^Hall JE (March 2003)."The kidney, hypertension, and obesity".Hypertension.41(3 Pt 2): 625–33.doi:10.1161/01.HYP.0000052314.95497.78.PMID12623970.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  22. ^Wofford MR, Hall JE (2004)."Pathophysiology and treatment of obesity hypertension".Curr. Pharm. Des.10(29): 3621–37.doi:10.2174/1381612043382855.PMID15579059.Retrieved2009-06-07.
  23. ^Davy KP, Hall JE (May 2004)."Obesity and hypertension: two epidemics or one?".Am. J. Physiol. Regul. Integr. Comp. Physiol.286(5): R803–13.doi:10.1152/ajpregu.00707.2003.PMID15068965.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  24. ^Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J (October 2003). "Impact of the obesity epidemic on hypertension and renal disease".Curr. Hypertens. Rep.5(5): 386–92.doi:10.1007/s11906-003-0084-z.PMID12948431.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  25. ^Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L (March 2003)."Obesity-associated hypertension and kidney disease".Curr. Opin. Nephrol. Hypertens.12(2): 195–200.doi:10.1097/01.mnh.0000058795.51455.3f(inactive 2023-08-02).PMID12589181.Retrieved2009-06-07.{{cite journal}}:CS1 maint: DOI inactive as of August 2023 (link) CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  26. ^Hall JE (April 2000). "Pathophysiology of obesity hypertension".Curr. Hypertens. Rep.2(2): 139–47.doi:10.1007/s11906-000-0073-4.PMID10981140.{{cite journal}}:CS1 maint: date and year (link)
  27. ^Brands MW, Hall JE, Keen HL (January 1998). "Is insulin resistance linked to hypertension?".Clin. Exp. Pharmacol. Physiol.25(1): 70–6.doi:10.1111/j.1440-1681.1998.tb02148.x.PMID9493563.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  28. ^Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M (August 1994). "Resistance to metabolic actions of insulin and its role in hypertension".Am. J. Hypertens.7(8): 772–88.doi:10.1093/ajh/7.8.772.PMID7986471.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  29. ^Hall JE, Brands MW, Zappe DH, Alonso Galicia M (April 1995). "Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations?".Proc. Soc. Exp. Biol. Med.208(4): 317–29.doi:10.3181/00379727-208-43862B.PMID7700881.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  30. ^Hall JE, Granger JP, Hester RL, Montani JP (October 1986). "Mechanisms of sodium balance in hypertension: role of pressure natriuresis".J Hypertens Suppl.4(4): S57–65.PMID3021942.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  31. ^Vargas Alarcón G (2006). "[Physiopathogenesis of hypertension]".Arch Cardiol Mex(in Spanish; Castilian).76(Suppl 2): S157–60.PMID17017092.{{cite journal}}:CS1 maint: unrecognized language (link)
  32. ^Naber CK, Siffert W (October 2004)."Genetics of human arterial hypertension".Minerva Med.95(5): 347–56.PMID15467511.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  33. ^Hermann M, Flammer A, Lüscher TF (December 2006)."Nitric oxide in hypertension".J Clin Hypertens (Greenwich).8(12 Suppl 4): 17–29.doi:10.1111/j.1524-6175.2006.06032.x.PMID17170603.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  34. ^Pośnik-Urbańska A, Kawecka-Jaszcz K (2006). "[Hypertension in postmenopausal women --selected pathomechanisms]".Prz. Lek.(in Polish).63(12): 1313–7.PMID17642147.
  35. ^Harrison-Bernard LM, Raij L (April 2000). "Postmenopausal hypertension".Curr. Hypertens. Rep.2(2): 202–7.doi:10.1007/s11906-000-0083-2.PMID10981150.{{cite journal}}:CS1 maint: date and year (link)
  36. ^Masszi G (December 2002). "[Hypertension and menopause]".Orv Hetil(in Hungarian).143(51): 2821–8.PMID12638308.{{cite journal}}:CS1 maint: date and year (link)
  37. ^Oparil S, Zaman MA, Calhoun DA (November 2003). "Pathogenesis of hypertension".Ann. Intern. Med.139(9): 761–76.doi:10.7326/0003-4819-139-9-200311040-00011.PMID14597461.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  38. ^Muratani H, Fukiyama K (April 1992). "[Pathogenesis of essential hypertension--a perspective]".Nippon Rinsho(in Japanese). 50 Suppl: 250–6.PMID1635200.{{cite journal}}:CS1 maint: date and year (link)
  39. ^Rossier BC (April 2003)."Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?".J. Clin. Invest.111(7): 947–50.doi:10.1172/JCI18232.PMC152592.PMID12671041.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  40. ^Katori M, Majima M (2006)."A missing link between a high salt intake and blood pressure increase".J. Pharmacol. Sci.100(5): 370–90.doi:10.1254/jphs.CRJ06003X.PMID16651701.Retrieved2009-06-07.
  41. ^Reckelhoff JF (May 2001)."Gender differences in the regulation of blood pressure".Hypertension.37(5): 1199–208.doi:10.1161/01.HYP.37.5.1199.PMID11358929.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  42. ^O'Shaughnessy KM, Karet FE (April 2004)."Salt handling and hypertension".J. Clin. Invest.113(8): 1075–81.doi:10.1172/JCI21560.PMC385413.PMID15085183.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  43. ^Carretero OA, Oparil S (January 2000)."Essential hypertension. Part I: definition and etiology".Circulation.101(3): 329–35.doi:10.1161/01.CIR.101.3.329.PMID10645931.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link)
  44. ^Lifton RP, Gharavi AG, Geller DS (February 2001)."Molecular mechanisms of human hypertension".Cell.104(4): 545–56.doi:10.1016/S0092-8674(01)00241-0.PMID11239411.Retrieved2009-06-07.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  45. ^Bähr V, Oelkers W, Diederich S (April 2003). "[Monogenic hypertension]".Med. Klin. (Munich)(in German).98(4): 208–17.doi:10.1007/s00063-003-1245-1.PMID12715144.{{cite journal}}:CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  46. ^Toka HR, Luft FC (March 2002). "Monogenic forms of human hypertension".Semin. Nephrol.22(2): 81–8.doi:10.1053/snep.2002.30206.PMID11891501.{{cite journal}}:CS1 maint: date and year (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Madhero88/Papers&oldid=936789418"